PeriGen Inc.

perigen.com

Formerly E&C Medical Intelligence ; Now PeriGen Solutions (a Halma company)

High-Tech Company

Acquired by Halma

Graduated from: VLVJ

TECH VERTICALS

Artificial Intelligence, Computer Vision, Digital Health, Healthcare IT, Healthtech, Life Sciences, Machine Learning, MedTech, Predictive Analytics

General Data

Sector	Digital Health
Company Stage:	Revenue Growth
Established	1995
Number of Employees	117

DESCRIPTION

PeriGen is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. It's customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems.
PeriGen’s unique fetal surveillance products provide dynamic visual cues that direct clinicians to the most essential patient information displayed on the screen. PeriGen Visual Cueing provides an instant view of the mother’s and baby’s current status and trends over time to prevent errors, increasing patient safety and reducing risk for clinicians and hospitals.

TECHNOLOGY

PeriGen’s AI-driven PeriWatch Vigilance® works alongside existing perinatal systems, adding an automated early warning system that quickly and easily helps labor & delivery clinicians identify patients who are developing worsening conditions. It works in tandem with current technology so “rip-and-replace” is not necessary.

Products and Phases

Product	Phase
PeriWatch Vigilance®	FDA Approved
PeriGen’s AI-driven PeriWatch Vigilance® works alongside existing perinatal systems, adding an automated early warning system that quickly and easily helps labor & delivery clinicians identify patients who are developing worsening conditions. It works in tandem with current technology so “rip-and-replace” is not necessary.

ESTIMATED ANNUAL SALES

	TARGET MARKETS
	Hospitals, Medical Institutions.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Cary, United States

Address	100 Regency Forest Drive, Suite 200
City	Cary
State/Province	NC
Country	United States
Zip	27518

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Montreal, QC, Canada

Address	245 Victoria, Suite 600
City	Montreal, QC
Country	Canada
Zip	H3Z 2M6

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Rishon Le-Zion, Israel

Address	2 Nim Blvd., Azrieli Rishonim
POB	110
City	Rishon Le-Zion
Country	Israel
Zip	7510002

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Matthew Sappern	CEO
Mr. Thomas J Garite	Chief Medical Officer
Mr. Edward Thompson	CFO
Dr. Alana McGolrick	Chief Nursing Officer
Ms. Emily Hamilton	SVP, Clinical Research & Development
Mr. Brian Bishop	CPO
Mr. Drew Narayan	CCO
Mr. Zach Schooler	Director of Business Development
Dr. Eyal Ephrat	Founder

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Apr. 27, 2021

Initial Revenues

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seventh Round

Sep. 27, 2016

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe	Led the round
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe

Sixth Round

Apr. 04, 2013

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe

Fifth Round

Jan. 11, 2010

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe

Fourth Round

Dec. 01, 2002

Initial Revenues

abCDe

Third Round

Nov. 01, 2001

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

Second Round

Apr. 01, 2000

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Investor	abCDe

First Round

Apr. 01, 1999

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Holding Company	abCDe

Seed

Oct. 01, 1995

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Incubator	abCDe

	Acquisitions made by PeriGen

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	N/A	Jul. 28, 2009	abCDe	Acquired assets from Montreal-based LMS Medical Systems Inc. for $3.5m.

Last Updated:	abCDe
IVC Number:	abCDe